Vogue Commercial Co. Ltd Income Statement-Bliss Gvs Pharma Ltd | Voguestock

INCOME STATEMENT

You can view the income statement for the last 5 years.
Bliss GVS Pharma Ltd.
( in Crs.)

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Net]917.18801.80765.91747.43737.93
Other Operating Revenues9.937.934.344.169.53
Total Operating Revenues927.11809.73770.24751.59747.45
      
Other Income73.5336.4928.7417.7931.49
Total Revenue1000.64846.22798.98769.37778.95
      
EXPENSES     
Cost Of Materials Consumed386.26372.51339.12330.04385.27
Purchase Of Stock-In Trade61.2549.2951.3544.3434.91
Changes In Inventories Of FG,WIP And Stock-In Trade-22.44-8.11-8.3526.94-29.20
Employee Benefit Expenses136.43112.0595.5886.1776.15
Finance Costs12.018.126.9110.364.74
Depreciation And Amortisation Expenses33.4829.4226.3818.6717.33
Other Expenses201.58157.30141.92146.77161.98
Total Expenses808.57720.58652.91663.30651.19
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax192.08125.64146.07106.07127.76
      
Exceptional Items-2.490.00-29.200.00-73.59
Profit/Loss Before Tax189.59125.64116.87106.0754.17
      
Tax Expenses-Continued Operations     
Current Tax68.0740.1332.4040.7539.14
Deferred Tax-14.33-3.992.03-11.51-4.74
Tax For Earlier Years1.12-0.750.860.09-3.35
Total Tax Expenses54.8635.3835.2929.3431.04
Profit/Loss After Tax And Before ExtraOrdinary Items134.7390.2681.5876.7323.13
      
Profit/Loss From Continuing Operations134.7390.2681.5876.7323.13
      
Profit/Loss For The Period134.7390.2681.5876.7323.13
      
Minority Interest-5.60-5.96-6.12-5.88-8.09
Consolidated Profit/Loss After MI And Associates129.1384.3075.4570.8615.04
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)12.238.027.236.831.46
Diluted EPS (Rs.)12.007.957.116.721.43
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend10.565.255.215.195.18
ParticularsMar 26
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]917.18
Other Operating Revenues9.93
Total Operating Revenues927.11
Other Income73.53
Total Revenue1000.64
EXPENSES 
Cost Of Materials Consumed386.26
Purchase Of Stock-In Trade61.25
Changes In Inventories Of FG,WIP And Stock-In Trade-22.44
Employee Benefit Expenses136.43
Finance Costs12.01
Depreciation And Amortisation Expenses33.48
Other Expenses201.58
Total Expenses808.57
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax192.08
Exceptional Items-2.49
Profit/Loss Before Tax189.59
Tax Expenses-Continued Operations 
Current Tax68.07
Deferred Tax-14.33
Tax For Earlier Years1.12
Total Tax Expenses54.86
Profit/Loss After Tax And Before ExtraOrdinary Items134.73
Profit/Loss From Continuing Operations134.73
Profit/Loss For The Period134.73
Minority Interest-5.60
Consolidated Profit/Loss After MI And Associates129.13
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)12.23
Diluted EPS (Rs.)12.00
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend10.56